RCAN1 and neurodegenerative disease: However, the good news is that Sun et al. discovered a new RCAN1 aptamer (RCAN1-s14) that was useful for preparing drugs for targeted inhibition of RCAN1 protein and treatment of e.g., Down syndrome, neurodegenerative diseases, inflammatory diseases, and cancer (Sun et al. 2022).